HomeIndustriesHealthcareBeta Bionics (BBNX) CEO on Advanced Diabetes Treatment & IPO
00:00
00:00
06:20
Beta Bionics (BBNX) CEO on Advanced Diabetes Treatment & IPO

Beta Bionics (BBNX) CEO on Advanced Diabetes Treatment & IPO

Sean Saint, CEO of Beta Bionics (BBNX), discusses the company’s IPO today and what the company does. Beta Bionics’ “bionic pancreas” is “the most automated” system to help control diabetes on the market, he says. He discusses why the system is better than regular insulin pumps, including its ability to learn and adapt, and how patients can access it.

Morning Trade Live

30 Jan 2025

SHARE

ON AIR
5:00 pm
Next Gen Investing
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Fast Market
REPLAY
8:00 am
Next Gen Investing
REPLAY
9:00 am
Market Overtime
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Inside the Mind of a Trader
REPLAY
education
10:30 am
Inside the Mind of a Trader
REPLAY
11:00 am
The Wrap
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
ON AIR
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
10:00 pm
Next Gen Investing
REPLAY
11:00 pm
The Wrap
REPLAY
12:00 am
Market Overtime
REPLAY
1:00 am
The Wrap
REPLAY
2:00 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor